Searched for
GLOBAL PHARMACEUTICAL MARKET
Beyond China, beyond tariffs: India, Japan look to MSMEs to turn strategic ties into factory-floor partnershipsAs Japanese Prime Minister Sanae Takaichi visits India, industry sees the biggest opportunity not in tariff concessions but in supplier eco...- These large- and mid-cap stocks can give more than 20% return in 1 year, according to analystsIn just a few days, the Q1 earnings season for FY27 will start. But before that will come the season of business updates. And that needs to...
- Sitharaman urges French firms to invest in India's AI, clean energy pushUnion Finance Minister Nirmala Sitharaman urged French businesses to boost investments in India, highlighting vast opportunities in AI, cle...
- For low risk-takers: 5 large-caps from different sectors with an upside potential of up to 31%Now, there is nothing wrong with being bullish, because it has always paid to be bullish. Yes, one might argue that it has not paid in the ...
- Shantha Biologics to Make Injectable Drug Cartridges for Novo NordiskShantha Biologics has secured a significant contract with Danish pharmaceutical giant Novo Nordisk to manufacture cartridges for injectable...
- Why did market rise today? Sensex gains 444 points, Nifty closes above 24,000. 3 key factorsIndian stock markets surged on Wednesday, breaking a two-day losing spell. Positive global sentiment and other factors propelled investor c...
- Lower crude, easing FII selling brighten market outlook; large-cap financials offer better value: Kunal VoraIndian equities are poised for a brighter outlook as crude oil prices retreat, corporate earnings show resilience, and foreign investor sel...
- Duty waiver on petrochemical products extended till July 15Indian manufacturers will continue to benefit from a full customs duty exemption on imported petrochemicals until July 15. This extension a...
- India's underperformance sets stage for recovery, says JM Financial's Deepak GuptaIndian equities are showing signs of a potential rebound, with attractive valuations and improved currency stability, according to Deepak G...
- Hyderabad is India's most expensive GCC office market, commands 15% premiumHyderabad has emerged as India's priciest office market for Global Capability Centres (GCCs), commanding a 15% premium. The city leads the ...
- For investors looking beyond the short-term horizon: 5 mid-cap stocks from different sectors with upside potential up to 28%All is once again quiet on the US-Iran war front, and some kind of dialogue to resolve the issues between the two seems to be still underwa...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 28%It is quite likely that the news cycle this and the next week will be about the direction of US interest rates and yield. If that turns out...
- India Inc's green transition triggers hiring surgeAs organisations step up their sustainability efforts, demand is also growing for senior leadership talent, including business heads for re...
- For investors with ability – and patience to wait 3 years, not 3 months: 6 large-cap stocks with upside potential of up to 33%The interesting point about the large-cap space today is not that prices have collapsed. In most cases, they have not. The more important c...
- Trade disruptions, API dependence, compliance costs: Pharma MSMEs spell out policy priorities on World MSME DayIndian pharmaceutical MSMEs are facing immense pressure from rising costs, supply chain woes, and stringent regulations. Industry represent...
- World MSME Day: Chemical industry seeks policy support to boost competitiveness amid global trade disruptionsIndian chemical industry leaders are urging a policy overhaul to boost competitiveness ahead of World MSME Day 2026. They highlight the nee...
- Zydus, Sunshine to set up $20 million pharma JV in Sri LankaIndian pharmaceutical giant Zydus Lifesciences has partnered with Sri Lanka's Sunshine Healthcare Lanka to establish a new manufacturing fa...
- Indian pharma firms gear up to supply key cancer drug to USIndian drugmakers are stepping up to help the US combat a critical shortage of ifosfamide injection, a vital chemotherapy drug. Leading com...
- NITI Aayog proposes pharma chapter for future FTAs, urges India to move up value chainNiti Aayog proposes a blueprint for free trade agreements to boost regulatory predictability in India's pharmaceutical sector. The think ta...
- India's pharma supply chain remains 65 per cent dependent on China for critical inputs: NITI AayogIndia's pharmaceutical sector, despite being the "pharmacy of the world," faces significant reliance on China for raw materials, with nearl...
Load More
